In conclusion, this study established a new noninvasive score model, which included CK-18 M30, CAP, FBG, and HBVDNA to diagnose NASH in patients with combined CHB and NAFLD. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatohepatitis.